Stars, Stripes, and Savings: Celebrate America’s 250th Anniversary with $250 Toward TRT
America is celebrating a milestone, and HerKare is celebrating it with you by offering $250 toward other services when you start testosterone replacement therapy (TRT).
Throughout the month of July, new patients who begin testosterone replacement therapy (TRT) through testosterone cypionate injections and remain on treatment for at least 90 days will receive $250 in account credit. No referral needed.
Now has never been a better time to know your baseline and find out whether low testosterone may be contributing to the way you feel. While testosterone is often thought of as a “man’s hormone”, it is just as important for women.
Testosterone Isn’t Just for Men
Women naturally produce testosterone in the ovaries. Although women have much lower levels than men, testosterone still plays an important role in overall health and wellbeing.
Healthy testosterone levels help support:
- Energy
- Sexual health
- Mood
- Mental clarity
- Bone health
- Recovery
- Overall quality of life
As women navigate life changes, especially perimenopause and menopause, testosterone levels decline naturally. For some women, this can lead to unwanted symptoms that disrupts everyday life.
Signs of Low Testosterone in Women
- Low libido
- Fatigue
- Brain fog
- Unexplained weight gain
- Thinning hair
- Irregular periods
- Low motivation
Why Personalized Care Matters
Every woman is different, and symptoms can vary widely from person to person.
TRT isn’t one-size-fits-all.
That’s why HerKare takes pride in individualized treatment plans, comprehensive lab testing, and ongoing provider support. Your care is tailored based on your hormone levels, symptoms, and how your body responds over time.
If treatment is recommended, HerKare uses pharmaceutical-grade testosterone cypionate injections and monitors your progress to help ensure treatment is safe and effective.
Discover the Benefits of Testosterone Therapy and Get $250
As part of our $250 for 250 celebration, eligible new patients who begin TRT in July and remain on treatment for at least 90 days will receive a $250 account credit to use toward future eligible HerKare services.
No referral is needed. Just start your TRT journey during this promotional period and continue your provider-led treatment plan.
Schedule your consultation with HerKare today to learn more about testosterone replacement therapy (TRT) for women and take advantage of this limited-time deal while the offer is still available!
Offer Details
Eligible patients must:
- Be a new HerKare patient beginning testosterone replacement therapy (TRT)
- Start testosterone cypionate injections between July 1st and July 31st, 2026
- Remain on treatment for at least 90 days
After meeting these requirements, patients will receive a $250 account credit applied to their account.
FAQs
When do I receive my $250 credit?
After you’ve remained on treatment for at least 90 days.
Who qualifies for the promotion?
New female patients who begin testosterone replacement therapy with testosterone cypionate injections between July 1st-31st, 2026.
Do I need a referral?
No. This promotion does not require a referral.
Can I receive cash instead?
No. The promotion provides a $250 account credit that may be used toward eligible HerKare services.
Can existing TRT patients participate?
No. This promotion is only available to new patients beginning TRT during the promotional period.
Terms & Conditions: Offer valid for new patients who begin testosterone replacement therapy (TRT) with testosterone cypionate injections between July 1 and July 31, 2026. Patients must remain on treatment for at least 90 days to qualify. Eligible patients will receive one (1) $250 account credit after completing the required treatment period. Credit is subject to the SynergenX Referral Credit Program Terms & Conditions, may be applied toward future eligible services, has no cash value, is non-transferable, expires one year from the date of issuance, and cannot be combined with other promotional account credit offers. Other restrictions may apply.